Report cover image

Analgesics in Japan

Published Sep 22, 2025
Length 26 Pages
SKU # EP20439427

Description

Retail value sales of analgesics are set to rise in current terms in Japan in 2025. During the year, Japan’s pharmaceutical landscape saw a significant shift as the national drug price revision excluded 94 items from the selective treatment reimbursement scheme. This change has led to increased out-of-pocket medical expenses, prompting more consumers to turn to over-the-counter (OTC) medicines before visiting healthcare institutions. The growing awareness of self-medication has played a key role...

Euromonitor International's Analgesics in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. Forecasts to 2029 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

26 Pages
Analgesics in Japan
Euromonitor International
September 2025
List Of Contents And Tables
ANALGESICS IN JAPAN
KEY DATA FINDINGS
2025 DEVELOPMENTS
Self-medication awareness and price revisions boost analgesics
Topical analgesics thrive despite new product launches and price adjustments
Eve brand celebrates 50 years and adapts to international regulations
PROSPECTS AND OPPORTUNITIES
Topical analgesics sustains market post-infection demand surge
Topical analgesics boosted by active seniors and lifestyle changes as OTC equivalents move beyond public health insurance
Switch to OTC and self-medication expansion key to market growth
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2020-2025
Table 2 Sales of Analgesics by Category: % Value Growth 2020-2025
Table 3 NBO Company Shares of Analgesics: % Value 2021-2025
Table 4 LBN Brand Shares of Analgesics: % Value 2022-2025
Table 5 Forecast Sales of Analgesics by Category: Value 2025-2030
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2025-2030
CONSUMER HEALTH IN JAPAN
EXECUTIVE SUMMARY
Consumer Health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2020-2025
Table 8 Life Expectancy at Birth 2020-2025
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2020-2025
Table 10 Sales of Consumer Health by Category: % Value Growth 2020-2025
Table 11 NBO Company Shares of Consumer Health: % Value 2021-2025
Table 12 LBN Brand Shares of Consumer Health: % Value 2022-2025
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2020-2025
Table 14 Distribution of Consumer Health by Format: % Value 2020-2025
Table 15 Distribution of Consumer Health by Format and Category: % Value 2025
Table 16 Forecast Sales of Consumer Health by Category: Value 2025-2030
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2025-2030
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources

Search Inside Report

How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.